Cloud 9fin Syndication Nation — The TLA-ming of the shrew
Feb 9, 2026
Sunny Oh, a senior reporter on leveraged finance, and Yiwen Lu, a reporter covering syndicated loans, unpack the resurgence of Term Loan A financings. They explain TLA features, why banks are using them to outmaneuver direct lenders, how TLAs showed up in recent jumbo buyouts like Hologic, and how the investor base and risks around flipping and covenant tradeoffs are evolving.
AI Snips
Chapters
Transcript
Episode notes
TLA Structural Advantages
- Term Loan As (TLAs) are prepayable, amortize faster, lack call protection, and typically cost less than TLBs.
- They historically filled financing gaps during turmoil but are now a deliberate tool in large LBOs.
Real Deals That Used TLAs
- Yiwen Lu cites several deals using TLAs, including Hologic's $1.225bn TLA and Biomarins' Amicus acquisition.
- These examples show TLAs appearing across M&A and jumbo buyouts, not just gap-filler cases.
Why This Year Feels Pivotal
- Market participants call this a potential watershed year because lenders hold spare capital and sponsors have ample dry powder.
- Rate-cut expectations and available liquidity are driving more M&A financing, increasing TLA use.